Oct 2, 2018 6:55 am EDT EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care
Sep 25, 2018 6:55 am EDT EyeGate Pharmaceuticals Granted Additional 180 Days to Comply With Nasdaq Listing Rules
Sep 24, 2018 6:55 am EDT EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies
Sep 4, 2018 8:31 am EDT EyeGate Announces Randomization of First Patients in Study for Punctate Epitheliopathies
Sep 4, 2018 8:30 am EDT EyeGate Announces Top-Line Results for Phase 3 Trial of EGP-437 in Anterior Uveitis
Aug 29, 2018 8:30 am EDT EyeGate Pharmaceuticals Announces Participation at the H.C. Wainwright 20th Annual Global Investment Conference
Aug 3, 2018 8:30 am EDT EyeGate Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update
Jul 24, 2018 8:30 am EDT EyeGate Announces FDA Approval of Two IDE Submissions for Ocular Bandage Gel